Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® for Non-Muscle Invasive ...

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
The Manila Times

Innventure, Inc. Announces Closing of $40 Million Registered Direct Offering of Common Stock

With the proceeds from the offering, Innventure expects to fully repay all outstanding convertible debentures ...